Cytomegalovirus seropositivity is associated with reduced risk of multiple sclerosis—a presymptomatic case–control study

Complete Epstein-Barr virus seropositivity in a large cohort of patients with early multiple sclerosis

(2020) Sargis Abrahamyan et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Epstein‐Barr virus infection after adolescence and Human herpesvirus 6A as risk factors for multiple sclerosis

(2020) Martin Biström et al.   EUROPEAN JOURNAL OF NEUROLOGY

Serum Neurofilament Light Chain Levels in Patients With Presymptomatic Multiple Sclerosis

(2019) Kjetil Bjornevik et al.   JAMA Neurology

A different response to cytomegalovirus (CMV) and Epstein–Barr virus (EBV) infection in UK people with multiple sclerosis (PwMS) compared to controls

(2019) Peter A.C. Maple et al.   JOURNAL OF INFECTION

Adaptive Features of Natural Killer Cells in Multiple Sclerosis

(2019) Antía Moreira et al.   Frontiers in Immunology

Increased Serological Response Against Human Herpesvirus 6A Is Associated With Risk for Multiple Sclerosis

(2019) Elin Engdahl et al.   Frontiers in Immunology

Low cytomegalovirus seroprevalence in early multiple sclerosis: a case for the ‘hygiene hypothesis’?

(2018) E. Alari-Pahissa et al.   EUROPEAN JOURNAL OF NEUROLOGY

Cytomegalovirus (CMV) seroprevalence in the adult population of Germany

(2018) Raskit Lachmann et al.   PLoS One

Validation of Multiplex Serology detecting human herpesviruses 1-5

(2018) Nicole Brenner et al.   PLoS One

Health-care use before a first demyelinating event suggestive of a multiple sclerosis prodrome: a matched cohort study

(2017) José M A Wijnands et al.   LANCET NEUROLOGY

Breastfeeding During Infancy Is Associated With a Lower Future Risk of Pediatric Multiple Sclerosis

(2017) J. Nicholas Brenton et al.   PEDIATRIC NEUROLOGY

Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis

(2016) Tomas Olsson et al.   Nature Reviews Neurology

Adaptive natural killer cell response to cytomegalovirus and disability progression in multiple sclerosis

(2015) Jose E Martínez-Rodríguez et al.   Multiple Sclerosis Journal

Adaptive natural killer cell response to cytomegalovirus and disability progression in multiple sclerosis

(2015) Jose E Martínez-Rodríguez et al.   Multiple Sclerosis Journal

The pathogenesis of human cytomegalovirus

(2014) Paul Griffiths et al.   JOURNAL OF PATHOLOGY

Cytomegalovirus and multiple sclerosis risk

(2013) Julia Pakpoor et al.   JOURNAL OF NEUROLOGY

Cytomegalovirus seropositivity is negatively associated with multiple sclerosis

(2013) E Sundqvist et al.   Multiple Sclerosis Journal

The risk of developing multiple sclerosis in individuals seronegative for Epstein-Barr virus: a meta-analysis

(2012) J. Pakpoor et al.   Multiple Sclerosis Journal

Epstein-Barr virus and multiple sclerosis: interaction with HLA

(2011) E Sundqvist et al.   GENES AND IMMUNITY

Common viruses associated with lower pediatric multiple sclerosis risk

(2011) E. Waubant et al.   NEUROLOGY

Primary infection with the epstein-barr virus and risk of multiple sclerosis

(2010) Lynn I. Levin et al.   ANNALS OF NEUROLOGY

Cytomegalovirus Seroprevalence in the United States: The National Health and Nutrition Examination Surveys, 1988–2004

(2010) Sheri Lewis Bate et al.   CLINICAL INFECTIOUS DISEASES

Human cytomegalovirus immunity and immune evasion

(2010) Sarah E. Jackson et al.   VIRUS RESEARCH

Antibodies to specific EBNA-1 domains and HLA DRB1⁎1501 interact as risk factors for multiple sclerosis☆

(2009) Peter Sundström et al.   JOURNAL OF NEUROIMMUNOLOGY

Cytomegalovirus and human immunosenescence

(2008) Graham Pawelec et al.   REVIEWS IN MEDICAL VIROLOGY